<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39058743</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Long-COVID symptom monitoring: Insights from a two-year telemedicine study.</ArticleTitle><Pagination><StartPage>e0307834</StartPage><MedlinePgn>e0307834</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0307834</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0307834</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients' lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by the COD19 telemedicine platform operations center. We recontacted patients who were initially monitored from February 2020 to May 2020 to assess the presence of Long-COVID symptoms at a 2-year follow-up.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted interviews to evaluate Long-COVID symptoms at the 2-year mark and investigated whether patients had contracted a second COVID-19 infection between the 1-year and 2-year follow-ups, and recorded their vaccination status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 165 patients, 139 (84%) reported symptoms at the 1-year follow-up, while only 101 (61%) reported symptoms at the 2-year follow-up. Among patients with Long-COVID symptoms at the 2-year follow-up, the majority (80, 49%) had experienced Long-COVID at the 1-year follow-up, received the SARS-CoV-2 vaccine, and had not experienced a second infection between the two follow-ups. Both having Long-COVID at the 1-year follow-up and contracting a second infection were significant risk factors for presenting with Long-COVID at the 2-year follow-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To the best of our knowledge, this study stands out as one of the few that includes a 2-year follow-up on Long-COVID symptoms using telemedicine. Telemedicine has proven to be an effective and innovative tool for long-term patient monitoring, early diagnosis, and treatment. Telemedicine represents a significant future challenge for healthcare.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Foppiani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foppiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Food, Environmental and Nutritional Sciences (DeFENS), International Center for the Assessment of Nutritional Status (ICANS), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Medicine, Clinical Nutrition Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montanari</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Department, "V. Buzzi" Children's Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanelli</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0005-7112-0522</Identifier><AffiliationInfo><Affiliation>Pediatric Department, "V. Buzzi" Children's Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardo</LastName><ForeName>Michele Davide Maria</ForeName><Initials>MDM</Initials><AffiliationInfo><Affiliation>Orthopaedics and Traumatology, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calcaterra</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2137-5974</Identifier><AffiliationInfo><Affiliation>Pediatric Department, "V. Buzzi" Children's Hospital, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccotti</LastName><ForeName>Gianvincenzo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Department, "V. Buzzi" Children's Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>28</Day><Hour>14</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39058743</ArticleId><ArticleId IdType="pmc">PMC11280159</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0307834</ArticleId><ArticleId IdType="pii">PONE-D-24-17457</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO). (2022). Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>NICE. (2023). COVID-19 rapid guideline: Managing COVID-19. National Institute for Health and Care Excellence (NICE; ): London, UK.</Citation><ArticleIdList><ArticleId IdType="pubmed">34181371</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023. Mar;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2 Epub 2023 Jan 13. Erratum in: Nat Rev Microbiol. 2023 Jun;21(6):408. ; PMCID: PMC9839201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S, Zhao Y, Zeng N, Liu X, Zheng Y, Sun J, et al.. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Mol Psychiatry. 2023. Oct;28(10):4056&#x2013;4069. doi: 10.1038/s41380-023-02171-3 Epub 2023 Jul 25. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021. Apr;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z Epub 2021 Mar 22. ; PMCID: PMC8893149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023. Mar 10;41(11):1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008 Epub 2023 Feb 8. ; PMCID: PMC9905096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccotti GV, Bertoli S, Foppiani A, Verduci E, Battezzati A. COD19 and COD20: An Italian Experience of Active Home Surveillance in COVID-19 Patients. Int J Environ Res Public Health. 2020. Sep 14;17(18):6699. doi: 10.3390/ijerph17186699 ; PMCID: PMC7560013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17186699</ArticleId><ArticleId IdType="pmc">PMC7560013</ArticleId><ArticleId IdType="pubmed">32938009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccotti G, Calcaterra V, Foppiani A. Present and future of telemedicine for pediatric care: an Italian regional experience. Ital J Pediatr. 2023. Jan 17;49(1):10. doi: 10.1186/s13052-023-01408-9 ; PMCID: PMC9843098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-023-01408-9</ArticleId><ArticleId IdType="pmc">PMC9843098</ArticleId><ArticleId IdType="pubmed">36650538</ArticleId></ArticleIdList></Reference><Reference><Citation>Indicazioni Nazionali per l&#x2019;erogazione Di Prestazioni in Telemedicina, Accordo Stato Regioni ai sensi Art.4 comma 1 D. Lgs. 28 agosto 1997, n.281 (2020). https://www.statoregioni.it/it/conferenza-stato-regioni/sedute-2020/seduta-del-17122020/atti/repertorio-atto-n-215csr/.</Citation></Reference><Reference><Citation>Zuccotti G, Calcaterra V. Telemedicine and E-Health: An Innovative Challenge in Pediatric Care. Int J Environ Res Public Health. 2023. Jan 23;20(3):2091. doi: 10.3390/ijerph20032091 ; PMCID: PMC9915758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20032091</ArticleId><ArticleId IdType="pmc">PMC9915758</ArticleId><ArticleId IdType="pubmed">36767457</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023. Jun 17;401(10393):e21&#x2013;e33. doi: 10.1016/S0140-6736(23)00810-3 Epub 2023 Jun 12. ; PMCID: PMC10258565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022. Nov;28(11):2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3 Epub 2022 Nov 10. ; PMCID: PMC9671810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al.. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023. Jun 1;183(6):566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750 ; PMCID: PMC10037203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al.. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022. Apr;28(4):611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002 Epub 2021 Nov 9. ; PMCID: PMC8575536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B, Wills M, Sithole N. Long COVID: what is known and what gaps need to be addressed. Br Med Bull. 2023. Sep 12;147(1):6&#x2013;19. doi: 10.1093/bmb/ldad016 ; PMCID: PMC10502447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldad016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al.. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022. Aug;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w Epub 2022 Jul 25. ; PMCID: PMC9388369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397 Epub 2021 May 22. ; PMCID: PMC8146298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Martono Fatmawati F, Mulyanti S. Risk Factors Associated with the Severity of COVID-19. Malays J Med Sci. 2023. Jun;30(3):84&#x2013;92. doi: 10.21315/mjms2023.30.3.7 Epub 2023 Jun 27. ; PMCID: PMC10325129.</Citation><ArticleIdList><ArticleId IdType="doi">10.21315/mjms2023.30.3.7</ArticleId><ArticleId IdType="pmc">PMC10325129</ArticleId><ArticleId IdType="pubmed">37425387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MC, Huang J, Wong YY, Wong GL, Yip TC, Chan RN, et al.. Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study. JMIR Public Health Surveill. 2023. Mar 7;9:e42315. doi: 10.2196/42315 ; PMCID: PMC9994465.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/42315</ArticleId><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="pubmed">36645453</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcaterra V, Tagi VM, D&#x2019;Auria E, Lai A, Zanelli S, Montanari C, et al.. Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study. Ital J Pediatr. 2024. Feb 14;50(1):27. doi: 10.1186/s13052-024-01596-y ; PMCID: PMC10865522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-024-01596-y</ArticleId><ArticleId IdType="pmc">PMC10865522</ArticleId><ArticleId IdType="pubmed">38355648</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>